{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:20:57Z","timestamp":1776298857243,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>This study addresses the gap in research comparing the effectiveness between home and in\u2010office narrowband ultraviolet B (NB\u2010UVB) phototherapy for the treatment of mycosis fungoides (MF). Elderly and disabled patients with this condition disproportionally lack access to home units due to insurance denial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A retrospective review included patients diagnosed with MF or Sezary syndrome who underwent either in\u2010office or home UVB between 2016 and 2023. Eighty\u2010four patients used home NB\u2010UVB, while 75 used in\u2010office. Clinical characteristics, treatment response, and access were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, there was no significant difference in response rates between home and in\u2010office NB\u2010UVB phototherapy. Subgroup analysis based on adjuvant treatment revealed a significant difference in clinical response rates for patients using NB\u2010UVB with topicals (<jats:italic>p<\/jats:italic>\u2009=\u20090.008) and NB\u2010UVB with multiple systemic therapies (<jats:italic>p<\/jats:italic>\u2009=\u20090.04). Financial and time constraints were the most common cause of treatment discontinuation for in\u2010office patients (28%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The effectiveness of home NB\u2010UVB treatment is comparable, if not superior, to in\u2010office treatment, likely attributed to treatment ease in access and compliance. Medicare and other health insurance companies should expand coverage to include home\u2010based phototherapy for patients with MF, a potentially fatal cancer with a relative paucity of effective alternate therapies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/phpp.13009","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T08:28:44Z","timestamp":1731745724000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Retrospective Comparison Between Home and in\u2010Office <scp>NB<\/scp>\u2010<scp>UVB<\/scp> Efficacy for Patients With Mycosis Fungoides"],"prefix":"10.1111","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-5613","authenticated-orcid":false,"given":"Victoria","family":"Garfinkel","sequence":"first","affiliation":[{"name":"Medical School University of Texas Southwestern Medical Center  Dallas Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan S.","family":"Reisch","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center  Dallas Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4186-4791","authenticated-orcid":false,"given":"Heather Woodworth","family":"Goff","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Texas Southwestern Medical Center  Dallas Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19182"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.033"},{"issue":"4","key":"e_1_2_10_4_1","first-page":"131","article-title":"Need for Expansion of Coverage for Narrowband UVB Phototherapy in Mycosis Fungoides and S\u00e9zary Syndrome","volume":"14","author":"Kim A.","year":"2021","journal-title":"American Health & Drug Benefits"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1365113"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12326"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.07.046"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1490"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12462"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_310_18"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.32.0630"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2019.08.013"},{"key":"e_1_2_10_13_1","volume-title":"SAS\/STAT 13.1 User's Guide","author":"SAS Institute Inc","year":"2013"},{"key":"e_1_2_10_14_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378\u20106323.152169"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418800947"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468\u20103083.2006.01557.x"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019\u20105154.113944"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.06.035"},{"issue":"2","key":"e_1_2_10_20_1","first-page":"31","article-title":"Home Ultraviolet Light Therapy for Psoriasis: Why Patients Choose Other Options","volume":"21","author":"Dothard E. H.","year":"2014","journal-title":"Dermatology Online Journal"},{"key":"e_1_2_10_21_1","volume-title":"Who's Eligible for Medicare","author":"US Department of Health and Human Services","year":"2022"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190\u20109622(93)70155\u2010M"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680170063007"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/phpp.13009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T13:22:45Z","timestamp":1733318565000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/phpp.13009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/phpp.13009"],"URL":"https:\/\/doi.org\/10.1111\/phpp.13009","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13009"}}